bifido

Bifidobacterium longum

bori

Global patented Bifidobacterium strain with
inhibition of rotavirus infection of infants

  • Isolated from the feces of
    healthy breast-feeding infants
  • US FDA GRAS Notification
    GRN No. 813
  • Deposited at the Korean
    Culture Center of Microbiology
    as KCCM 10492
  • US Patented
    [US20040938162] / Complete
    genomic sequenced

Bio-functional
effects

Bifidobacterium longum BORI showed 99% inhibition of the rotavirus infection in the experimental model. It was identified as a single protein named BORI (Bifidobacterium Original Rotavirus Inhibition) by our research team.

GUT

  • · Anti-rotavirus PDF

BRAIN

  • · Cognitive function PDF
  • · State of emotion PDF

KIDNEY

Global
Notifications

Featured in
book chapters

B. longum BORI, originated from a breast fed infant, is well documented regarding clinical evidence for its health promoting effects by various researchers of universities and hospitals and have been featured in the international textbooks of microbiology.

Global
application

More
References

Certificate

  • • Non-GMO
  • • BSE-free
  • • TSE-free
  • • No Allergen
  • • Halal Certi

Packaging

  • • 1kg / pack
  • • 10pack/box

Safety

  • • US FDA GRAS approved
  • • US FDA NDI approved
  • • Whole Genome Sequencing
  • • 30 years without side effect

Storage Condition

Be kept in an airtight container
and stored at a temperature not
exceeding 8℃

top으로 이동